Natural News

AstraZeneca announced on Tuesday, June 15, that the antibody cocktail it has been developing failed to stop Wuhan coronavirus (COVID-19) symptoms from appearing.

The trial, named “Storm Chaser,” was on Phase III. It involved 1,121 adult volunteers from the United States and the United Kingdom. The vast majority of the volunteers did not have COVID-19 symptoms at the start of the trial. But they were exposed to the coronavirus soon after the trial started.

AstraZeneca claimed the goal of the trial was to figure out whether the long-acting antibody cocktail it developed could protect people who had recently been in contact with coronavirus-positive persons in places like nursing homes. (Related: QUACKERY: After granting EUA to COVID vaccines for antibody response, FDA now says antibodies are useless.)

READ FULL ARTICLE HERE > https://www.naturalnews.com/2021-06-21-astrazeneca-antibody-cocktail-fails-prevent-symptoms-coronavirus.html

Similar Posts

Leave a Reply

Your email address will not be published.